ES554061A0 - Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma - Google Patents

Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma

Info

Publication number
ES554061A0
ES554061A0 ES554061A ES554061A ES554061A0 ES 554061 A0 ES554061 A0 ES 554061A0 ES 554061 A ES554061 A ES 554061A ES 554061 A ES554061 A ES 554061A ES 554061 A0 ES554061 A0 ES 554061A0
Authority
ES
Spain
Prior art keywords
butyrolactma
procedure
preparation
new
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554061A
Other languages
English (en)
Other versions
ES8704457A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese Academy of Medical Sciences CAMS
Bayer AG
Original Assignee
Chinese Academy of Medical Sciences CAMS
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Academy of Medical Sciences CAMS, Bayer AG filed Critical Chinese Academy of Medical Sciences CAMS
Publication of ES554061A0 publication Critical patent/ES554061A0/es
Publication of ES8704457A1 publication Critical patent/ES8704457A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Package Frames And Binding Bands (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES554061A 1984-08-24 1986-04-16 Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma Expired ES8704457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431257 DE3431257A1 (de) 1984-08-24 1984-08-24 Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung

Publications (2)

Publication Number Publication Date
ES554061A0 true ES554061A0 (es) 1987-04-01
ES8704457A1 ES8704457A1 (es) 1987-04-01

Family

ID=6243847

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546381A Expired ES8609241A1 (es) 1984-08-24 1985-08-23 Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina.
ES554061A Expired ES8704457A1 (es) 1984-08-24 1986-04-16 Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES546381A Expired ES8609241A1 (es) 1984-08-24 1985-08-23 Nuevas butirolactamas, composiciones farmacologicamente activas de las mismas, procedimientos para su obtencion y su empleo en medicina.

Country Status (16)

Country Link
US (1) US4879390A (es)
EP (1) EP0172514B1 (es)
JP (1) JPH0660159B2 (es)
KR (1) KR860001787A (es)
AT (1) ATE46504T1 (es)
AU (1) AU571729B2 (es)
CA (1) CA1262250A (es)
DE (2) DE3431257A1 (es)
DK (1) DK385285A (es)
ES (2) ES8609241A1 (es)
FI (1) FI853228L (es)
GR (1) GR852050B (es)
HU (1) HU195774B (es)
IL (1) IL76157A (es)
PT (1) PT81005B (es)
ZA (1) ZA856414B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579029B2 (en) * 1985-10-18 1988-11-10 Bayer Aktiengesellschaft Process for the preparation of ` -butyrolactams
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3927367A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
JP4585073B2 (ja) * 2000-02-15 2010-11-24 丸善製薬株式会社 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品
EP1348696B1 (en) * 2002-03-26 2012-02-01 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
CN1295215C (zh) * 2002-12-31 2007-01-17 中国医学科学院药物研究所 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI325174A (es) * 1973-11-19 1975-05-20 Sandoz Ag

Also Published As

Publication number Publication date
JPS62181250A (ja) 1987-08-08
DK385285A (da) 1986-02-25
PT81005B (en) 1987-06-26
FI853228A0 (fi) 1985-08-22
GR852050B (es) 1985-12-20
ZA856414B (en) 1986-04-30
DK385285D0 (da) 1985-08-23
ES8609241A1 (es) 1986-07-16
IL76157A0 (en) 1985-12-31
DE3431257A1 (de) 1986-03-06
KR860001787A (ko) 1986-03-22
HUT38904A (en) 1986-07-28
ATE46504T1 (de) 1989-10-15
IL76157A (en) 1988-08-31
JPH0660159B2 (ja) 1994-08-10
HU195774B (en) 1988-07-28
US4879390A (en) 1989-11-07
AU4657185A (en) 1986-02-27
EP0172514A1 (en) 1986-02-26
FI853228L (fi) 1986-02-25
CA1262250A (en) 1989-10-10
ES8704457A1 (es) 1987-04-01
EP0172514B1 (en) 1989-09-20
PT81005A (en) 1985-09-01
DE3573113D1 (en) 1989-10-26
ES546381A0 (es) 1986-07-16
AU571729B2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
ES8801785A1 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
IL62018A (en) Dipeptidyl agmatine derivatives,their preparation and pharmaceutical compositions containing them
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
DK446684A (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES554061A0 (es) Un procedimiento para la preparacion de una composicion farmaceutica que contiene como ingrediente activo una nueva a -butirolactma
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
JO1406B1 (en) Chemical compounds
HUT56556A (en) Process for producing new piperazinecarboxamides containing phenoxyalkyl or thiophenoxyalkyl side chain, as well as pharmaceutical compositions comprising such compounds as active ingredient
EP0033156A3 (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives, intermediates and process for their preparation, medicines containing them and their use as pharmaceutically active compounds
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
ES8102147A1 (es) Procedimiento para la obtencion de derivados de sisomicina
IT1190426B (it) Derivati del flavolignano,procedimento per la loro preparazione e medicinali che contengono questi composti
IE781610L (en) Antithrombotic composition
DE2961935D1 (en) 4-nitro-2-trichloromethylphenyl disulfides, process for their preparation, means containing them as active ingredient and use against microorganisms
DE3062531D1 (en) Pyrrolidine derivatives, processes for their preparation and pharmaceutical compositions containing them
DE2960718D1 (en) Antibacterial monic acid c derivatives, processes for their preparation and compositions containing them
ZA81986B (en) Novel indane derivatives,process for their preparation,their use as pharmaceuticals and pharmaceutical compositions containing said derivatives
DE3372772D1 (en) Quinazolinone derivatives, process for their preparation and their use in medicaments
EP0353631A3 (en) Isoxazolobenzoxazepines, a process for their preparation and their use as medicaments
IT1208533B (it) Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli